Patents by Inventor Tobias Laich

Tobias Laich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical preparation of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide
    Patent number: 8784887
    Abstract: The invention relates to a pharmaceutical preparation for oral administration comprising N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide or its hydrates and/or solvates, as well as an acid, a method for its production as well as the use of this preparation for the treatment and/or prophylaxis of diseases which are caused by herpes viruses, in particular diseases which are caused by herpes simplex viruses.
    Type: Grant
    Filed: September 27, 2007
    Date of Patent: July 22, 2014
    Assignee: Aicuris GmbH & Co. KG
    Inventors: Tobias Laich, Katrin Liebelt
  • ORALLY DISINTEGRATING TABLET CONTAINING ACARBOSE
    Publication number: 20130131003
    Abstract: It was an object of the present invention to provide an orally disintegrating tablet (ODT) for the glycosidase inhibitor acarbose. The object is achieved with an orally disintegrating tablet containing 1-30% acarbose and 40-90% water-soluble carrier. In order to obtain the desired properties, the ingredients have to be precompacted and to be premixed with an insoluble carrier.
    Type: Application
    Filed: April 26, 2011
    Publication date: May 23, 2013
    Applicant: BAYER INTELLECTUAL PROPERTY GMBH
    Inventors: Axel Schneeweis, Tobias Laich
  • Topical application of thiazolyl amides
    Patent number: 7883713
    Abstract: The invention relates to the topical application of substituted thiazolyl amides in the treatment of herpes infections in humans, to preparations suitable for the topical application and to the production thereof.
    Type: Grant
    Filed: June 10, 2002
    Date of Patent: February 8, 2011
    Assignee: AiCuris GmbH & Co. KG
    Inventors: Ulrich Betz, Tobias Laich, Wolfgang Bender, Ruediger Fischer, Martin Hendrix, Gerald Kleymann
  • Pharmaceutical preparation of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide
    Publication number: 20080220059
    Abstract: The invention relates to a pharmaceutical preparation for oral administration comprising N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide or its hydrates and/or solvates, as well as an acid, a method for its production as well as the use of this preparation for the treatment and/or prophylaxis of diseases which are caused by herpes viruses, in particular diseases which are caused herpes simplex viruses.
    Type: Application
    Filed: September 27, 2007
    Publication date: September 11, 2008
    Inventors: Tobias Laich, Katrin Liebelt
  • Topical application of thiazolyl amides
    Publication number: 20040235917
    Abstract: The invention relates to the topical application of substituted thiazolyl amides in the treatment of herpes infections in humans, to preparations suitable for the topical application and to the production thereof.
    Type: Application
    Filed: June 30, 2004
    Publication date: November 25, 2004
    Inventors: Ulrich Betz, Tobias Laich, Wolfgang Bender, Rudiger Fischer, Martin Hendrix, Gerald Kleymann
  • Method for producing pharmaceutical dosage forms
    Publication number: 20030031720
    Abstract: The invention relates to a method for producing a granulate while using spray-dried D-mannitol and to the production of pharmaceutical dosage forms comprised of granulates of this type. The invention additionally relates to granulates obtained by using this method and to pharmaceutical dosage forms, which contain statins, especially cerivastatin, and which can be produced from said granulates.
    Type: Application
    Filed: August 23, 2002
    Publication date: February 13, 2003
    Inventors: Tobias Laich, Carola Prtner, Jan-Olav Henck
  • Medicament formulation with a controlled release of an active agent
    Patent number: 6270799
    Abstract: The invention relates to drug formulations which comprise 1-cyclopropyl-7-([S,S]-2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quino-lonecarboxylic acid and/or pharmaceutically tolerable salts thereof and/or hydrates thereof as active compound which release the active compound they contain at a defined release rate.
    Type: Grant
    Filed: March 17, 2000
    Date of Patent: August 7, 2001
    Assignee: Bayer Aktiengesellscahft
    Inventors: Hans-Martin Siefert, Patrick Bosché, Heino Stass, Stefan Kettelhoit, Tobias Laich